Overview
Endothelin receptors (ETRs) are transmembrane proteins that bind endothelin peptides, which are among the most potent vasoconstrictors known. Discovered in 1988, these receptors exist as two pharmacologically distinct subtypes: ETA (Endothelin Receptor Type A) and ETB (Endothelin Receptor Type B), encoded by EDNRA and EDNRB genes respectively. They belong to the Class A rhodopsin-like GPCR family and are widely expressed in vascular endothelial cells, smooth muscle, and organs like the lungs and kidneys. The ETA receptor primarily mediates vasoconstriction and cell proliferation, while ETB receptors have dual roles - endothelial ETB causes vasodilation via nitric oxide release, whereas smooth muscle ETB induces vasoconstriction. Dysregulation of endothelin signaling is implicated in pulmonary arterial hypertension (PAH), chronic kidney disease, and cancer progression, making these receptors important therapeutic targets.
Physical and Chemical Properties
As integral membrane proteins, endothelin receptors exhibit typical GPCR topology with seven transmembrane α-helices, an extracellular N-terminus for ligand binding, and intracellular loops for G protein coupling. The ETA receptor shows higher affinity for endothelin-1 (ET-1) than ET-3 (ET-1>ET-2>>ET-3), while ETB binds all three isoforms equally. Both subtypes signal through Gq (activating phospholipase C) and Gi (inhibiting adenylate cyclase) pathways. Biophysical studies reveal that receptor activation involves conformational changes upon endothelin binding, particularly in the transmembrane domains. The receptors form homo- and heterodimers, which may modulate signaling. Their structural complexity makes crystallization challenging, though computational models guide drug design. Stability varies by cellular context, with half-lives ranging from hours to days depending on trafficking and recycling mechanisms.
Main Applications
In clinical medicine, endothelin receptor antagonists (ERAs) like bosentan (dual ETA/ETB), ambrisentan (ETA-selective), and macitentan are FDA-approved for pulmonary arterial hypertension, improving exercise capacity and hemodynamics. Research applications include studying cardiovascular remodeling, renal fibrosis, and tumor angiogenesis, where ET-1 signaling promotes disease progression. Pharmaceutical companies actively develop novel ERAs with improved selectivity and safety profiles. Diagnostic applications utilize ET receptor imaging probes for detecting atherosclerosis and cancer metastases. In biotechnology, engineered ET receptors serve as biosensors for high-throughput screening of cardiovascular drugs. Agricultural research explores their role in plant stress responses, suggesting potential crop protection applications.
Safety and Storage
Recombinant endothelin receptors and related research reagents require careful handling. Cell lines expressing ETRs should be maintained under sterile conditions with appropriate biosafety levels (typically BSL-2). Isolated receptor proteins are unstable at room temperature and should be stored at -80°C with cryoprotectants like glycerol. When working with endothelin peptides or receptor modulators, use proper PPE (gloves, lab coats) as ET-1 can elevate blood pressure. Dispose of biological waste according to institutional guidelines. For pharmaceutical formulations containing ERAs, follow manufacturer storage recommendations (commonly 15-30°C for oral tablets). Stability testing indicates most ERAs degrade under high humidity or light exposure.
B2B Procurement Guide
For research procurement, specify: 1) Receptor subtype (ETA/ETB/both), 2) Host system (human, rat, etc.), 3) Format (antibodies, cell lines, membrane preparations), and 4) Validation data required (binding assays, knockout controls). Leading suppliers include Sigma-Aldrich, Abcam, and R&D Systems for antibodies; Eurofins and DiscoverX for screening services. Bulk orders of receptor antagonists for pharmaceutical manufacturing require GMP certification and detailed analytical profiles. Pricing varies significantly: research-grade materials range from $200-$5,000 per unit, while clinical-grade compounds cost substantially more. Lead times extend to 8-12 weeks for custom recombinant proteins. Consider purchasing through specialized distributors for cardiovascular research reagents to access technical support and batch consistency guarantees.
Related Manufacturers
- 主营：大鼠白介素、小鼠脂联素、表皮生长因子、人内皮素受体B、ELISA试剂盒、细胞因子、重组蛋白
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、内皮素1受体ELISA试剂盒、蛋白、抗体、细胞、检测试剂盒
- 主营：igg抗体、糖蛋白、试剂盒、样受体、脂蛋白、人瘦素、粗纤维、猪睾酮、烯二酮、nad激酶、测试盒、牛瘦素、牛胆酸、原果胶、磷酸酶、犬肾素、含水量、人蛋白、甜菜碱、igm抗体、dna抗体、磷脂酶、大鼠超、犬叶酸、人胆酸
- 主营：酶cγ链、α2巨球、素d合成、人内皮素受体AelisaKit、纤连蛋白、抗组蛋白、肌醇抗体、蛋白样环、敏感蛋白、牛骨钙素、蛋白重链、金属肽酶、乳球蛋白、钩端螺旋、蛋白激酶、高血糖素、钙调蛋白、小鼠α1抗、ELISA试剂盒、pcr检测试剂、生化检测试剂
- 主营：检测方、钠尿肽、试剂盒、人内皮素受体A、同源物、ep300检测、结合蛋白、大鼠c-肽(、微球蛋白、抗胰蛋白酶、淋巴瘤因子、蛋白磷酸酶、死亡激动剂、核心域蛋白1、大鼠e选择素、大鼠janus激酶、激活蛋白激酶、大鼠ⅱ型胶原、大鼠ⅳ型胶原、大鼠klotho蛋白、细胞激活因子、大鼠ⅲ型胶原、大鼠nadh脱氢酶1、大鼠ⅵ型胶原α1、elisa 检测试剂盒
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、人内皮素受体A、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、内皮素受体AELISA试剂盒、蛋白、抗体、细胞
- 主营：内皮素受体A、elisa试剂盒
- 主营：ELISA试剂盒、生化检测试剂盒、PCR试剂盒、大鼠ELISA试剂盒、小鼠ELISA试剂盒、兔ELISA试剂盒、鸡ELISA试剂盒
- 主营：兔内皮素受体B、elisa 试剂盒
- 主营：大鼠内皮素受体B、试剂盒、信号调节激酶、人转谷氨酰胺酶
- 主营：试剂盒、辅激活因子、elisa试剂盒、人内皮素受体B、蛋白、多肽、金标试剂盒、PCR试剂盒、抗生素、氨基酸、血清、抗体
- 主营：内皮素受体A、elisa试剂盒、试剂盒、抗体
- 主营：内皮素受体B、elisa试剂盒、分子生物学试剂及试剂盒、各种抗体及免疫学试剂盒
- 主营：试剂盒、脂蛋白、胆固醇、褪黑素、同源盒、源蛋白、磷酸酶、信号素、整合素、鹦鹉衣、脂肪酶、类固醇、蛋白酶、氧化酶、中段肽、羟化酶、凝集素、白三烯、松弛肽、催乳素、肌酸受、白介素、质激素